[Changes in platelets, coagulation and fibrinolysis in patients with chronic kidney diseases and hemodialysis].
Terada
H
H
Department of Internal Medicine, St Luke's College of Nursing.
D001550:Benzamidines; D001777:Blood Coagulation; D001792:Blood Platelets / Q000502:physiology; D011464:Epoprostenol / Q000627:therapeutic use; D005342:Fibrinolysis; D016670:Gabexate / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000628:therapy; D009404:Nephrotic Syndrome / Q000097:blood* / Q000628:therapy; D010976:Platelet Count; D006435:Renal Dialysis
D001550:Benzamidines; D006146:Guanidines; D016670:Gabexate; D006493:Heparin; D011464:Epoprostenol; C032855:nafamostat